Healthcare delivery

The collaboration will focus on connecting business functions, improving access to information and using emerging technologies, including artificial intelligence (AI), to support faster decision-making across the Group.

Under the agreement, Mediclinic Middle East will engage with HealthTech startups within Hub71+ Life Sciences to identify potential collaborations and provide clinical guidance.

Researchers used patient-derived tumor tissue to investigate whether the technology could improve drug delivery and make tumors more responsive to treatment.

Under the agreement, ADSCC will contribute its cell therapy development and manufacturing infrastructure, while Miltenyi will provide scientific and technical support for its proprietary viral vector and anti-CD19 chimeric antigen receptor technologies.

Mediclinic Middle East is exploring how ambient AI can capture relevant information from clinician-patient conversations and convert it into structured clinical notes for review, reducing the need for manual documentation during consultations.

The project will increase inpatient and outpatient capacity, upgrade existing departments and introduce new orthopaedic and physiotherapy services.

The clinic brings together specialists in surgery, oncology, radiology, and reconstruction, along with nursing and patient coordination services.

The meeting combines an African subregional workshop with the closing session of the Global Environment Facility’s (GEF) GEF-7 Phasing Down Dental Amalgam Project.

The opening expands the hospital’s oncology services as healthcare providers increasingly focus on coordinated cancer care those addresses treatment needs, side effects and patients’ quality of life.

Building on its inaugural edition in 2025, the conference expanded its scientific programme to include lectures, clinical case discussions, practical workshops and panel sessions led by Egyptian and international experts.